Community Pharmacy England (CPE) - News updates
Medicine Supply Notification: Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets. MSN/2026/002 Tier 2 – Medium impact Date of issue: 15 January 2026 Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets were discontinued on 5th January 2026. Various strengths (0.7mg/0.18mg, 1.4mg/0.36mg, 5.7mg/1.4mg, 8.6mg/2.1mg, and 11.4mg/2.9mg) of [...] The post Medicine Supply Notification: Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets appeared first on Community Pharmacy England.
PQS declaration questions published
The NHS Business Services Authority (NHSBSA) has published the questions which will be included in the 2025/26 Pharmacy Quality Scheme (PQS) declaration so pharmacy owners can view these ahead of making their declaration when the declaration window opens. The questions are available on the NHSBSA PQS hub page; scroll down to the ‘PQS 2025/26’ section where [...] The post PQS declaration questions published appeared first on Community Pharmacy England.
Supporting you in 2026: Our work with Pharmacist Support
Alongside critical work making the financial case for the sector, Community Pharmacy England will be working with Pharmacist Support in 2026 to help support the wellbeing of pharmacists and their teams. The continuing fragility of pharmacy finances, alongside high workloads, stress, ongoing uncertainty and rising reports of patient abuse across England, take a real toll [...] The post Supporting you in 2026: Our work with Pharmacist Support appeared first on Community Pharmacy England.
Discontinuation of Subutex® and Suboxone® tablets
Update 15/01/2026: DHSC has issued a Medicine supply Notification for Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets. Pharmacy teams should be aware that all strengths of Subutex® and Suboxone® tablets have been discontinued. The manufacturer, Indivior, is no longer supplying these products in the UK therefore, they are no longer available for community pharmacies [...] The post Discontinuation of Subutex® and Suboxone® tablets appeared first on Community Pharmacy England.
Pharmacy First myth busting: To reject or not to reject?
This article tackles some of the misconceptions around rejecting Pharmacy First referrals and aims to bust myths to increase understanding of the service. We have previously published a series of articles on myth busting covering a variety of aspects of Pharmacy First. All of these myths can be viewed on our Pharmacy First service – [...] The post Pharmacy First myth busting: To reject or not to reject? appeared first on Community Pharmacy England.
Medicine Supply Notification: Co-codamol 30mg/500mg tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Co-codamol 30mg/500mg tablets. MSN/2026/001 Tier 3 – High impact Date of issue: 12 January 2026 Co-codamol 30mg/500mg tablets will be in limited supply from early February until early June 2026. Paracetamol 500mg tablets remain available and can support a full uplift [...] The post Medicine Supply Notification: Co-codamol 30mg/500mg tablets appeared first on Community Pharmacy England.
Seasonal Vaccination Service 2026/27 – webinar
Community Pharmacy England will be holding a webinar in collaboration with NHS England about the new Seasonal Vaccination Service on Wednesday 21st January at 7.30pm. The new Advanced service covers the provision of both seasonal vaccinations (COVID-19 and adult flu) in community pharmacy for the 2026/27 season. On the night David Onuoha, Service Development Manager and [...] The post Seasonal Vaccination Service 2026/27 – webinar appeared first on Community Pharmacy England.
Cleen Ready-to-use enema Drug Tariff price adjustment – November and December 2025
The Department of Health and Social Care (DHSC) has confirmed that prescriptions for Cleen Ready-to-use 133ml enema (Sodium dihydrogen phosphate dihydrate 18.1% / Disodium hydrogen phosphate dodecahydrate 8% 133ml enema) dispensed in November and December 2025 will be correctly reimbursed based on its increased NHS list price which had not been reflected in the published [...] The post Cleen Ready-to-use enema Drug Tariff price adjustment – November and December 2025 appeared first on Community Pharmacy England.
New NHS Healthy Choices Quiz
The Department of Health and Social Care (DHSC) and the NHS have launched a new campaign encouraging all adults to take the new NHS Healthy Choices Quiz. This health and wellbeing quiz aims to empower adults to take control of their health by making small changes day to day. The quiz, which takes around 5 [...] The post New NHS Healthy Choices Quiz appeared first on Community Pharmacy England.
PQS: Have you started your AMS Pharmacy First audit?
Pharmacy owners have until 3rd February 2026 to start the Pharmacy Quality Scheme (PQS) Antimicrobial Stewardship – Pharmacy First consultations – Clinical Audit. The audit, which is a quality criterion in the Patient safety domain of the 2025/26 PQS, requires pharmacy owners to complete a clinical audit focused on the clinical advice and consultations provided to patients [...] The post PQS: Have you started your AMS Pharmacy First audit? appeared first on Community Pharmacy England.